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RELATO DE CASO 
MAL DE POTT EM PACIENTE IMUNOSSUPRIMIDO, UM RELATO 
DE CASO 
POTT DISEASE IN IMMUNOSUPRESSED PATIENT, A CASE REPORT 
Heloyse Nascimento Lima¹, Rômulo Braga Pires¹, Angélica Gomes de 
Carvalho¹, Isabella Vilane Braga Saboia Rythowem¹, Pedro Miranda Portugal 
Junior¹, Clara Leticia Rocha Silva¹, Olívia Maria Veloso Coutinho². 
RESUMO 
A tuberculose (TB) é uma doença infectocontagiosa, de transmissão aérea causada 
pelo Mycobacterium tuberculosis. A forma pulmonar é mais frequente, mas outras 
estruturas corporais podem ser acometidas. O Mal de Pott (MP) é uma entidade 
rara e corresponde a cerca de 0,5% - 1% da manifestação extrapulmonar, 
principalmente em pacientes imunossuprimidos. Ocorre através da reativação de 
sítios para a coluna e as vezes membros inferiores. A sintomatologia se apresenta 
através da tríade: abscesso, paraplegia e gibosidade, associado ao quadro clínico 
clássico da TB pulmonar: febre, sudorese noturna e calafrios. O objetivo deste 
estudo é demonstrar um caso de Mal de Pott em uma paciente do sexo feminino 
de 56 anos, com história prévia de quimioterapia devido Linfoma não Hodgkin. 
Após instituído tratamento paciente evoluiu com melhora sintomática e bom 
desfecho clínico.  
Palavras-chave: Tuberculose. Extrapulmonar. Imunossupressão. 
 
ABSTRACT 
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. 
The pulmonary form is more frequent, but other body structures may be affected. 
Pott's Disease is a rare entity and accounts for about 0.5% - 1% of extrapulmonary 
manifestation, especially in immunosuppressed patients. It occurs through 
reactivation of sites for the spine and sometimes lower limbs. The 
symptomatology presents itself through the triad: abscess, paraplegia and 
gibbosity, associated with the classic clinical picture of pulmonary TB: fever, night 
sweats and chills. The aim of this study is to demonstrate a case of Pott's disease 
in a 56-year-old female patient with a history of chemotherapy due to non-
Hodgkin's lymphoma. After treatment, the patient evolved with symptomatic 
improvement and good clinical outcome. 
Keywords: Tuberculosis. Extrapulmonary. Immunosuppression. 
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INTRODUCTION 
 
Tuberculosis (TB) is an infectious disease caused by 
Mycobacterium tuberculosis, or Koch's Bacillus, which is 
transmitted by air¹. It is an endemic disease in developing 
countries, according to the new WHO 2016-2020 
classification. Brazil ranks 20th in the list of 30 countries with 
most TB². Pulmonary infection may remain latent and may 
progress to symptomatic forms and spread to other parts of 
the body such as meninges, bones, lymph nodes and skin.  
Pott's Disease (MP), described by Sir Percivall Pott in 1779 and 
1782³, receives this name in honor and corresponds to about 
0.5% - 1% of the extrapulmonary manifestation of TB4, being 
more common. In immunosuppressed patients, such as HIV-
positive patients, patients undergoing chemotherapy. It occurs 
through reactivation of focus via hematogenous or 
lymphatically metastatic pathway to the spine, preferentially 
affecting joints and weight-bearing bones, such as lower limbs 
and spine5. The symptomatology is presented through the 
triad: abscess, paraplegia and gibbosity6, associated with 
classic TB clinic: fever, night sweats and chills. 
 
CASE REPORT 
  
A.N.G.O, 56 years old, female, married, brown, 
housewife, born in Tupiram - TO, living in Palmas - TO. The 
patient was admitted in the Palmas Public General Hospital 
(HGPP) with pain in the interscapular chest region, which did 
not give way with the use of common analgesics. He also had 
fevers, with intense night sweats, associated with dyspnea and 
asthenia beginning approximately two months ago. Patient 
has a previous history of diffuse large B-cell non-Hodgkin's 
lymphoma in which he underwent chemotherapy treatment 
and presented complete remission of the disease a year ago. 
The patient underwent a new magnetic resonance imaging 
(MRI), which showed an image that may correspond to the 
intraosseous abscess in the lower vertebral plateau of D6 
(figure 1), with involvement of the surrounding soft tissues 
and reactive bone hyperemia in the vertebral plateau higher 
than D7 (figure 2). 
 
Figure 1 
 
Figure 2 
 
 
He underwent biopsy of the vertebral abscess, and 
the diagnosis was confirmed by histopathological findings: 
chronic granulomatous osteomyelitis with areas of caseous 
necrosis favoring the diagnosis of tuberculosis or tuberculous 
spondylitis (Pott's disease). Unidentified BAAR. Treatment 
with the RIPE regimen (two months of rifampicin, isoniazid, 
pyrazinamide and ethambutol + four months of rifampicin and 
isoniazid) was instituted. After the treatment, the patient 
evolved with symptomatology improvements, was discharged 
after the seventh day of hospital treatment with maintenance 
of tuberculostatic use and ambulatory follow-up.  
 
DISCUSSION / CONCLUSION 
 Pott's Disease is a neglected disease, mainly because 
it affects people with low purchasing power. In addition, the 
underdiagnoses of the disease is responsible for often 
irreversible sequels, and we should always be suspicious of 
prolonged dorsal pain symptomatology 7.  
Among the tuberculosis pandemic and the increasing 
number of cases of HIV + patients, as well as individuals 
immunosuppressed by transplants, chemotherapy drugs and 
immunodepressions, the appearance of extrapulmonary 
tuberculosis in this group of people is becoming more 
common 8. In immunocompromised patients with HIV, the 
diagnosis becomes even more difficult, due to the fact that 
Pott can coexist between other pathologies such as infectious 
arthritis, rheumatologic diseases and spinal cord diseases that 
occur relatively more frequently in these individuals 9.  
The clinical diagnosis of Pott Mall presents low 
specificity. The manifestations of the disease vary and depend 
on the age of the patient, the location of the infection, 
absence or presence of abscess and disease stage 10. Because 
of this, the diagnosis is made based on clinical suspicion, with 
associating imaging such as MRI, which demonstrates the 
affection of the vertebral bodies, as well as the destruction of 
the discs, cold abscesses, vertebrae collapse and spinal 
deformities 6. Radiological examinations bring varied findings 
of bone deformity, reduction of intervertebral space, kyphotic 
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deformity and, frequently, presence of cold abscesses in the 
surroundings 11. The exams of choice for diagnostic 
investigation are CT and MRI. However, the gold standard for 
the diagnosis of Pott's disease is CT-guided biopsy, leading the 
collected material to microbiological, molecular and 
histopathological studies 12.  
In immunocompetents patients, there is increased 
morbidity and mortality of both diseases, especially if the 
treatment is not submitted, and there may be permanent 
limitations to the patient 13.  
Treatment is with tuberculostatic: rifampicin + 
isoniazid + pyrazinamide + ethambutol for two months, 
followed by rifampicin + isoniazid for a maximum of 4, 6, 9, 12 
or 18 months 14.  
Surgical treatment is indicated when the patient 
evolves with increased spinal deformity, progressive 
neurological deficit, pain due to abscess or vertebral 
instability, when not responding to conservative treatment 
and uncertain diagnosis 15.  
Spinal TB manifestations are uncommon, but are 
more prevalent in immunocompromised patients. Delay in 
diagnosis makes it difficult to start treatment and may favor 
complicated forms of the disease, such as paraplegia. Knowing 
that Brazil is endemic area of TB, we should always suspect of 
patients with prolonged dorsal pain associated with the clinic. 
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